Citations (96)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (13)
Kevin Y. Wang, Pratik Shah, Brandon Skavla, Fatima Fayyaz, Jeffrey Chi & Joanna M. Rhodes. (2023) Vaccination efficacy in patients with chronic lymphocytic leukemia. Leukemia & Lymphoma 64:1, pages 42-56.
Read now
Read now
Beatrice Sim, Jun Yen Ng, Benjamin W. Teh & Dipti Talaulikar. (2023) Immunoglobulin replacement in hematological malignancies: a focus on evidence, alternatives, dosing strategy, and cessation rule. Leukemia & Lymphoma 64:1, pages 18-29.
Read now
Read now
Eleftheria Kampouri, Carla S. Walti, Jordan Gauthier & Joshua A. Hill. (2022) Managing hypogammaglobulinemia in patients treated with CAR-T-cell therapy: key points for clinicians. Expert Review of Hematology 15:4, pages 305-320.
Read now
Read now
Vishesh Patel & Juthaporn Cowan. (2020) Discontinuation of immunoglobulin replacement therapy in patients with secondary antibody deficiency. Expert Review of Clinical Immunology 16:7, pages 711-716.
Read now
Read now
Jessica L. Dempsey, Andrew Johns, Ashley E. Rosko & Hillard M. Lazarus. (2019) The pharmacologic management of multiple myeloma in older adults. Expert Opinion on Pharmacotherapy 20:7, pages 887-902.
Read now
Read now
Omar Benbrahim, Jean-François Viallard, Sylvain Choquet, Bruno Royer, Frédéric Bauduer, Olivier Decaux, Jean-Charles Crave, Yann Fardini, Pierre Clerson & Vincent Lévy. (2019) The use of octagam and gammanorm in immunodeficiency associated with hematological malignancies: a prospective study from 21 French hematology departments. Hematology 24:1, pages 173-182.
Read now
Read now
Tamar Tadmor, Manfred Welslau & Iwona Hus. (2018) A review of the infection pathogenesis and prophylaxis recommendations in patients with chronic lymphocytic leukemia. Expert Review of Hematology 11:1, pages 57-70.
Read now
Read now
Carlo Agostini, Igor-Wolfgang Blau, Eva Kimby & Torben Plesner. (2016) Prophylactic immunoglobulin therapy in secondary immune deficiency – an expert opinion. Expert Review of Clinical Immunology 12:9, pages 921-926.
Read now
Read now
Igor-Wolfgang Blau, Niall Conlon, Robert Petermann, Nikolai Nikolov & Torben Plesner. (2016) Facilitated subcutaneous immunoglobulin administration (fSCIg): a new treatment option for patients with secondary immune deficiencies. Expert Review of Clinical Immunology 12:7, pages 705-711.
Read now
Read now
Jasleen K. Randhawa & Alessandra Ferrajoli. (2016) A review of supportive care and recommended preventive approaches for patients with chronic lymphocytic leukemia. Expert Review of Hematology 9:3, pages 235-244.
Read now
Read now
Xiao-xiao Xu, Bei Yan, Zhen-xing Wang, Yong Yu, Xiao-xiong Wu & Yi-zhuo Zhang. (2013) Fludarabine-based versus CHOP-like regimens with or without rituximab in patients with previously untreated indolent lymphoma: a retrospective analysis of safety and efficacy. OncoTargets and Therapy 6, pages 1385-1392.
Read now
Read now
Tobias Svensson, Martin Höglund & Honar Cherif. (2013) Clinical significance of serum immunoglobulin G subclass deficiency in patients with chronic lymphocytic leukemia. Scandinavian Journal of Infectious Diseases 45:7, pages 537-542.
Read now
Read now
Jane A. Freeman, Kyle R. Crassini, O. Giles Best, Cecily J. Forsyth, Naomi J. Mackinlay, Ping Han, William Stevenson & Stephen P. Mulligan. (2013) Immunoglobulin G subclass deficiency and infection risk in 150 patients with chronic lymphocytic leukemia. Leukemia & Lymphoma 54:1, pages 99-104.
Read now
Read now
Articles from other publishers (83)
Kyle Crassini & John Gibson. (2023) Pathogenesis and management of immune dysfunction secondary to B cell haematological malignancies. Internal Medicine Journal.
Crossref
Crossref
Makiko Suga, Shigeo Fuji, Yuma Tada, Kazuhito Tsutsumi, Shuhei Kida, Kumi Shibata, Ryo Nakata, Yasuhiro Shingai, Sayako Yuda, Takafumi Yokota & Jun Ishikawa. (2023) A single‐institution pre–post comparison of subcutaneous immunoglobulin replacement therapy in allogeneic haematopoietic cell transplantation recipients. British Journal of Haematology.
Crossref
Crossref
Ernestina Angarola, Verónica Andrea Peuchot, Fernando Warley & Diana Inés Liberatore. (2023) Secondary hypogammaglobulinemia in adults—A large retrospective cohort study. Medicina Clínica.
Crossref
Crossref
Ernesto Gargiulo, Eduardo Flavio Oliveira Ribeiro & Carsten U. Niemann. (2023) SOHO State of the Art Updates and Next Questions | Infections in Chronic Lymphocytic Leukemia Patients: Risks and Management. Clinical Lymphoma Myeloma and Leukemia 23:5, pages 322-332.
Crossref
Crossref
Alessandro Noto, Ramona Cassin, Veronica Mattiello, Marta Bortolotti, Gianluigi Reda & Wilma Barcellini. (2023) Should treatment of hypogammaglobulinemia with immunoglobulin replacement therapy (IgRT) become standard of care in patients with chronic lymphocytic leukemia?. Frontiers in Immunology 14.
Crossref
Crossref
Maria Kislova, Andrei Petrenko, Elena A. Dmitrieva, Alexander Milenkin, Konstantin E. Nikitin, Vadim V. Ptushkin, Alexey V. Shabunin & Eugene A. Nikitin. (2023) Significant reduction in the incidence of non‐coronavirus infections in patients with chronic lymphocytic leukemia on ibrutinib and venetoclax treatment during the COVID‐19 pandemic: An additional benefit of lockdown. Hematological Oncology.
Crossref
Crossref
Ann Tran, Krista Marcon, David Zamar, Jian Mi, Jodi Shad, Joey Zheng, Hamish Nicolson, Rodrigo Onell & Andrew W. Shih. (2023) Evaluation of immunoglobulin replacement therapy in secondary immunodeficiency at three British Columbia hospitals. Vox Sanguinis.
Crossref
Crossref
Robert Puckrin, Mona Shafey & Jan Storek. (2023) The role of allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia: A review. Frontiers in Oncology 12.
Crossref
Crossref
Mahmoud SakrMahmoud Sakr. 2023. Lateral Neck Swellings. Lateral Neck Swellings
59
163
.
Siraj A. Misbah. 2022. Practical Transfusion Medicine. Practical Transfusion Medicine
426
440
.
Alexandre Nguyen, Nicolas Martin-Silva, Hubert De Boysson, Samuel Deshayes, Anne-Claire Gac, Emilie Reboursière, Gandhi Damaj & Achille Aouba. (2022) Low total gamma globulin level discovery at diffuse large B-cell lymphoma diagnosis predicts high risk of infection-related death: data from a monocentric retrospective study. Swiss Medical Weekly 152:2324, pages w30143.
Crossref
Crossref
Akihiro Ohmoto, Shigeo Fuji, Kendall C. Shultes, Bipin N. Savani & Hermann Einsele. (2022) Controversies about immunoglobulin replacement therapy in HSCT recipients with hypogammaglobulinemia. Bone Marrow Transplantation 57:6, pages 874-880.
Crossref
Crossref
Stephanie Villeneuve & Catherine Aftandilian. (2022) Neutropenia and Infection Prophylaxis in Childhood Cancer. Current Oncology Reports 24:6, pages 671-686.
Crossref
Crossref
Hartmut Link, Markus Kerkmann & Laura Holtmann. (2022) Immunoglobulin substitution in patients with secondary antibody deficiency in chronic lymphocytic leukemia and multiple myeloma: a representative analysis of guideline adherence and infections. Supportive Care in Cancer 30:6, pages 5187-5200.
Crossref
Crossref
Iris M. Otani, Heather K. Lehman, Artemio M. Jongco, Lulu R. Tsao, Antoine E. Azar, Teresa K. Tarrant, Elissa Engel, Jolan E. Walter, Tho Q. Truong, David A. Khan, Mark Ballow, Charlotte Cunningham-Rundles, Huifang Lu, Mildred Kwan & Sara Barmettler. (2022) Practical guidance for the diagnosis and management of secondary hypogammaglobulinemia: A Work Group Report of the AAAAI Primary Immunodeficiency and Altered Immune Response Committees. Journal of Allergy and Clinical Immunology 149:5, pages 1525-1560.
Crossref
Crossref
Larry D Anderson Jr. (2022) Idecabtagene vicleucel (ide-cel) CAR T-cell therapy for relapsed and refractory multiple myeloma. Future Oncology 18:3, pages 277-289.
Crossref
Crossref
Richard LeBlanc, Debra J. Bergstrom, Julie Côté, Rami Kotb, Martha L. Louzada & Heather J. Sutherland. (2022) Management of Myeloma Manifestations and Complications: The Cornerstone of Supportive Care: Recommendation of the Canadian Myeloma Research Group (formerly Myeloma Canada Research Network) Consensus Guideline Consortium. Clinical Lymphoma Myeloma and Leukemia 22:1, pages e41-e56.
Crossref
Crossref
Samantha Pozzi, Alessia Bari, Martin Pecherstorfer & Sonia Vallet. (2021) Management of Adverse Events and Supportive Therapy in Relapsed/Refractory Multiple Myeloma. Cancers 13:19, pages 4978.
Crossref
Crossref
Carsten Utoft Niemann. (2021) Management of Infections in Patients with CLL. Clinical Lymphoma Myeloma and Leukemia 21, pages S136-S138.
Crossref
Crossref
Laura Gengenbach, Giulia Graziani, Heike Reinhardt, Amelie Rösner, Magdalena Braun, Mandy-Deborah Möller, Christine Greil, Ralph Wäsch & Monika Engelhardt. (2021) Choosing the Right Therapy for Patients with Relapsed/Refractory Multiple Myeloma (RRMM) in Consideration of Patient-, Disease- and Treatment-Related Factors. Cancers 13:17, pages 4320.
Crossref
Crossref
A. Brand, V. De Angelis, T. Vuk, O. Garraud, M. Lozano & D. Politis. (2021) Review of indications for immunoglobulin (IG) use: Narrowing the gap between supply and demand. Transfusion Clinique et Biologique 28:1, pages 96-122.
Crossref
Crossref
Alessandro Busca, Chiara Cattaneo, Elena De Carolis, Gianpaolo Nadali, Massimo Offidani, Marco Picardi, Anna Candoni, Eleonora Ceresoli, Marianna Criscuolo, Mario Delia, Roberta Della Pepa, Ilaria Del Principe, Roma. Rosa Fanci, Francesca Farina, Nicola Fracchiolla, Claudia Giordano, Michele Malagola, Francesco Marchesi, Monica Piedimonte, Lucia Prezioso, Angela Maria Quinto, Angelica Spolzino, Maria Chiara Tisi, Fabio Trastulli, Enrico Maria Trecarichi, Patrizia Zappasodi, Mario Tumbarello & Livio Pagano. (2021) Considerations on antimicrobial prophylaxis in patients with lymphoproliferative diseases: A SEIFEM group position paper. Critical Reviews in Oncology/Hematology 158, pages 103203.
Crossref
Crossref
Andy Sing Ong Tang, Tze Shin Leong, Lee Ping Chew & Hock Hin Chua. (2021) Successful Non-surgical Treatment of an Acute Calculous Cholecystitis in a Myeloma Patient with Covid-19: Case Report. SN Comprehensive Clinical Medicine 3:2, pages 666-669.
Crossref
Crossref
B. Eichhorst, T. Robak, E. Montserrat, P. Ghia, C.U. Niemann, A.P. Kater, M. Gregor, F. Cymbalista, C. Buske, P. Hillmen, M. Hallek & U. Mey. (2021) Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology 32:1, pages 23-33.
Crossref
Crossref
Charanpreet Singh, Deepesh Lad, Arihant Jain, Gaurav Prakash, Alka Khadwal & Pankaj Malhotra. (2020) Resolution of high output pulmonary edema due to hyperviscosity with plasma exchange in a patient with multiple myeloma- a case report. Transfusion and Apheresis Science 59:6, pages 102898.
Crossref
Crossref
Davide Rossi, Mazyar Shadman, Adalgisa Condoluci, Jennifer R. Brown, John C. Byrd, Gianluca Gaidano, Michael Hallek, Peter Hillmen, Anthony Mato, Emili Montserrat & Paolo Ghia. (2020) How We Manage Patients With Chronic Lymphocytic Leukemia During the SARS-CoV-2 Pandemic. HemaSphere 4:4, pages e432.
Crossref
Crossref
Holly J. Edington, Kathryn S. Sutton, Carolyn Bennett, Shanmuganathan Chandrakasan, Jennifer Sterner‐Allison & Sharon M. Castellino. (2020) Dealing with a critical national shortage—Approaches to triaging immune globulin supply in pediatric hematology and oncology. Pediatric Blood & Cancer 67:7.
Crossref
Crossref
Joshua A. Hill & Susan Seo. (2020) How we prevent infections in patients receiving CD19-targeted chimeric antigen receptor T-cells for B-cell malignancies. Blood.
Crossref
Crossref
Farrukh T. Awan & John C. Byrd. 2020. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology
1850
1871.e5
.
Martin Bruun Madsen, Helena Bergsten & Anna Norrby-Teglund. 2020. Necrotizing Soft Tissue Infections. Necrotizing Soft Tissue Infections
105
125
.
Joshua A. HillElizabeth M. KrantzKevin A. Hay, Sayan DasguptaTerry Stevens-AyersRachel A. Bender Ignacio, Merav BarJoyce MaaloufSindhu Cherian, Xueyan Chen, Greg Pepper, Stanley R. RiddellDavid G. MaloneyMichael J. BoeckhCameron J. Turtle. (2019) Durable preservation of antiviral antibodies after CD19-directed chimeric antigen receptor T-cell immunotherapy. Blood Advances 3:22, pages 3590-3601.
Crossref
Crossref
Bradley S Figgins, Samuel L Aitken & Laura K Whited. (2019) Optimization of intravenous immune globulin use at a comprehensive cancer center. American Journal of Health-System Pharmacy 76:Supplement_4, pages S102-S106.
Crossref
Crossref
Emily A. Holmes, Debra L. Friedman, James A. Connelly, Daniel E. Dulek, Zhiguo Zhao & Adam J. Esbenshade. (2019) Impact of IgG Monitoring and IVIG Supplementation on the Frequency of Febrile Illnesses in Pediatric Acute Lymphoblastic Leukemia Patients Undergoing Maintenance Chemotherapy. Journal of Pediatric Hematology/Oncology 41:6, pages 423-428.
Crossref
Crossref
Il‐Kang Na, Matthew Buckland, Carlo Agostini, John David M. Edgar, Vanda Friman, Mauricette Michallet, Silvia Sánchez‐Ramón, Carmen Scheibenbogen & Isabella Quinti. (2019) Current clinical practice and challenges in the management of secondary immunodeficiency in hematological malignancies. European Journal of Haematology 102:6, pages 447-456.
Crossref
Crossref
Corrado Girmenia, Michele Cavo, Massimo Offidani, Francesco Scaglione, Alessandro Corso, Francesco Di Raimondo, Pellegrino Musto, Maria Teresa Petrucci & Giovanni Barosi. (2019) Management of infectious complications in multiple myeloma patients: Expert panel consensus-based recommendations. Blood Reviews 34, pages 84-94.
Crossref
Crossref
Talal Hilal, Juan C. Gea-Banacloche & Jose F. Leis. (2018) Chronic lymphocytic leukemia and infection risk in the era of targeted therapies: Linking mechanisms with infections. Blood Reviews 32:5, pages 387-399.
Crossref
Crossref
Omar Benbrahim, Jean-François Viallard, Sylvain Choquet, Bruno Royer, Frédéric Bauduer, Olivier Decaux, Jean-Charles Crave, Yann Fardini, Pierre Clerson & Vincent Lévy. (2018) A French observational study describing the use of human polyvalent immunoglobulins in hematological malignancy-associated secondary immunodeficiency. European Journal of Haematology 101:1, pages 48-56.
Crossref
Crossref
Heinz Ludwig, Michel Delforge, Thierry Facon, Hermann Einsele, Francesca Gay, Philippe Moreau, Hervé Avet-Loiseau, Mario Boccadoro, Roman Hajek, Mohamad Mohty, Michele Cavo, Meletios A Dimopoulos, Jesús F San-Miguel, Evangelos Terpos, Sonja Zweegman, Laurent Garderet, María-Victoria Mateos, Gordon Cook, Xavier Leleu, Hartmut Goldschmidt, Graham Jackson, Martin Kaiser, Katja Weisel, Niels W. C. J. van de Donk, Anders Waage, Meral Beksac, Ulf H. Mellqvist, Monika Engelhardt, Jo Caers, Christoph Driessen, Joan Bladé & Pieter Sonneveld. (2018) Prevention and management of adverse events of novel agents in multiple myeloma: a consensus of the European Myeloma Network. Leukemia 32:7, pages 1542-1560.
Crossref
Crossref
Kyle R. Crassini, Eva Zhang, Shalini Balendran, Jane A. Freeman, O. Giles Best, Cecily J. Forsyth, Naomi J. Mackinlay, Ping Han, William S. Stevenson & Stephen P. Mulligan. (2018) Humoral immune failure defined by immunoglobulin class and immunoglobulin G subclass deficiency is associated with shorter treatment‐free and overall survival in Chronic Lymphocytic Leukaemia. British Journal of Haematology 181:1, pages 97-101.
Crossref
Crossref
Masumi Ueda, Melvin Berger, Robert Peter Gale & Hillard M. Lazarus. (2018) Immunoglobulin therapy in hematologic neoplasms and after hematopoietic cell transplantation. Blood Reviews 32:2, pages 106-115.
Crossref
Crossref
Stephanie B. Dixon, Adam Lane, Maureen M. O'Brien, Karen C. Burns, Jennifer L. Mangino, Erin H. Breese, Michael J. Absalon, John P. Perentesis & Christine L. Phillips. (2018) Viral surveillance using PCR during treatment of AML and ALL. Pediatric Blood & Cancer 65:1, pages e26752.
Crossref
Crossref
Sarah E. Stump, Allison J. Schepers, Alexis R. Jones, Maurice D. Alexander & Jessica J. Auten. (2017) Comparison of Weight-Based Dosing Strategies for Intravenous Immunoglobulin in Patients with Hematologic Malignancies. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 37:12, pages 1530-1536.
Crossref
Crossref
Marcel Reiser, Michael Borte, Dörte Huscher, Ulrich Baumann, David Pittrow, Claudia Sommer, Martin Stangel, Maria Fasshauer, Ralf Gold & Manfred Hensel. (2017) Management of patients with malignancies and secondary immunodeficiencies treated with immunoglobulins in clinical practice: Long-term data of the SIGNS study. European Journal of Haematology 99:2, pages 169-177.
Crossref
Crossref
José A. García-Marco, Julio Delgado, José A. Hernández-Rivas, Ángel Ramírez Payer, Javier Loscertales Pueyo, Isidro Jarque, Pau Abrisqueta, Pilar Giraldo, Rafael Martínez, Lucrecia Yáñez, Mª José Terol, Marcos González & Francesc Bosch. (2017) Actualización de las guías nacionales de consenso del Grupo Español de Leucemia Linfocítica Crónica para el tratamiento y seguimiento de la leucemia linfocítica crónica. Medicina Clínica 148:8, pages 381.e1-381.e9.
Crossref
Crossref
José A. García-Marco, Julio Delgado, José A. Hernández-Rivas, Ángel Ramírez Payer, Javier Loscertales Pueyo, Isidro Jarque, Pau Abrisqueta, Pilar Giraldo, Rafael Martínez, Lucrecia Yáñez, M. José Terol, Marcos González & Francesc Bosch. (2017) Update of the Grupo Español de Leucemia Linfocítica Crónica clinical guidelines of the management of chronic lymphocytic leukemia. Medicina Clínica (English Edition) 148:8, pages 381.e1-381.e8.
Crossref
Crossref
John A. Snowden, Diana M. Greenfield, Jennifer M. Bird, Elaine Boland, Stella Bowcock, Abigail Fisher, Eric Low, Monica Morris, Kwee Yong & Guy Pratt. (2017) Guidelines for screening and management of late and long-term consequences of myeloma and its treatment. British Journal of Haematology 176:6, pages 888-907.
Crossref
Crossref
Elena E. Perez, Jordan S. Orange, Francisco Bonilla, Javier Chinen, Ivan K. Chinn, Morna Dorsey, Yehia El-Gamal, Terry O. Harville, Elham Hossny, Bruce Mazer, Robert Nelson, Elizabeth Secord, Stanley C. Jordan, E. Richard Stiehm, Ashley A. Vo & Mark Ballow. (2017) Update on the use of immunoglobulin in human disease: A review of evidence. Journal of Allergy and Clinical Immunology 139:3, pages S1-S46.
Crossref
Crossref
Sapna Srivastava & Philip Wood. (2016) Secondary antibody deficiency – causes and approach to diagnosis. Clinical Medicine 16:6, pages 571-576.
Crossref
Crossref
B. Eichhorst, T. Robak, E. Montserrat, P. Ghia, P. Hillmen, M. Hallek & C. Buske. (2016) appendix 6: Chronic lymphocytic leukaemia: eUpdate published online September 2016 (http://www.esmo.org/Guidelines/Haematological-Malignancies). Annals of Oncology 27, pages v143-v144.
Crossref
Crossref
Silvia Sánchez-Ramón, Fatima Dhalla & Helen Chapel. (2016) Challenges in the Role of Gammaglobulin Replacement Therapy and Vaccination Strategies for Hematological Malignancy. Frontiers in Immunology 7.
Crossref
Crossref
Siobhan V. Glavey & Nelson Leung. (2016) Monoclonal gammopathy: The good, the bad and the ugly. Blood Reviews 30:3, pages 223-231.
Crossref
Crossref
Charles L. BennettTerhi Hermanson. (2016) Big data, thromboembolism, and immunoglobulin. Blood 127:2, pages 171-172.
Crossref
Crossref
Eric M. Ammann, Michael P. JonesBrian K. LinkRyan M. Carnahan, Scott K. Winiecki, James C. Torner, Bradley D. McDowell, Bruce H. Fireman & Elizabeth A. Chrischilles. (2016) Intravenous immune globulin and thromboembolic adverse events in patients with hematologic malignancy. Blood 127:2, pages 200-207.
Crossref
Crossref
John A. Hooper. (2015) The history and evolution of immunoglobulin products and their clinical indications. LymphoSign Journal 2:4, pages 181-194.
Crossref
Crossref
Fatima Dhalla & Siraj A. Misbah. (2015) Secondary antibody deficiencies. Current Opinion in Allergy & Clinical Immunology 15:6, pages 505-513.
Crossref
Crossref
Federico De Angelis, Maria Elena Tosti, Saveria Capria, Eleonora Russo, Gianna Maria D’Elia, Giorgia Annechini, Caterina Stefanizzi, Robin Foà & Alessandro Pulsoni. (2015) Risk of secondary hypogammaglobulinaemia after Rituximab and Fludarabine in indolent non-Hodgkin lymphomas: A retrospective cohort study. Leukemia Research 39:12, pages 1382-1388.
Crossref
Crossref
Bart L. Scott & Brenda M. Sandmaier. 2015. Thomas’ Hematopoietic Cell Transplantation. Thomas’ Hematopoietic Cell Transplantation
349
365
.
B. Eichhorst, T. Robak, E. Montserrat, P. Ghia, P. Hillmen, M. Hallek & C. Buske. (2015) Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology 26, pages v78-v84.
Crossref
Crossref
Krzysztof Jamroziak & Agnieszka Końska. (2015) Substytucja immunoglobulin u chorych na przewlekłą białaczkę limfocytową i szpiczaka plazmocytowego. Acta Haematologica Polonica 46:3, pages 233-241.
Crossref
Crossref
Jacqueline Kerr, Isabella Quinti, Martha Eibl, Helen Chapel, Peter J. Späth, W. A. Carrock Sewell, Abdulgabar Salama, Ivo N. van Schaik, Taco W. Kuijpers & Hans-Hartmut Peter. (2014) Is Dosing of Therapeutic Immunoglobulins Optimal? A Review of a Three-Decade Long Debate in Europe. Frontiers in Immunology 5.
Crossref
Crossref
M. Seppänen. (2014) Immunoglobulin G treatment of secondary immunodeficiencies in the era of novel therapies. Clinical & Experimental Immunology 178, pages 10-13.
Crossref
Crossref
Antonio Cuneo, Monia Marchetti, Giovanni Barosi, Atto Billio, Maura Brugiatelli, Stefania Ciolli, Luca Laurenti, Francesca Romana Mauro, Stefano Molica, Marco Montillo, Pierluigi Zinzani & Sante Tura. (2014) Appropriate use of bendamustine in first-line therapy of chronic lymphocytic leukemia. Recommendations from SIE, SIES, GITMO Group. Leukemia Research 38:11, pages 1269-1277.
Crossref
Crossref
Mathieu Blot, Pierre Boyer, Maxime Samson, Sylvain Audia, Hervé Devilliers, Vanessa Leguy, Sabine Berthier, Jean-François Besancenot, Bernard Lorcerie, Daniela Lakomy & Bernard Bonnotte. (2014) Should mild hypogammaglobulinemia be managed as severe hypogammaglobulinemia? A study of 389 patients with secondary hypogammaglobulinemia. European Journal of Internal Medicine 25:9, pages 837-842.
Crossref
Crossref
E. Sarmiento, J. Navarro, J. Fernandez‐Yañez, J. Palomo, P. Muñoz & J. Carbone. (2014) Evaluation of an immunological score to assess the risk of severe infection in heart recipients. Transplant Infectious Disease 16:5, pages 802-812.
Crossref
Crossref
W. A. Carrock Sewell, Jacqueline Kerr, Marie-Emmanuelle Behr-Gross & Hans-Hartmut Peter. (2014) European consensus proposal for immunoglobulin therapies. European Journal of Immunology 44:8, pages 2207-2214.
Crossref
Crossref
Benjamin W. Teh, Simon J. Harrison, Marc Pellegrini, Karin A. Thursky, Leon J. Worth & Monica A. Slavin. (2014) Changing treatment paradigms for patients with plasma cell myeloma: Impact upon immune determinants of infection. Blood Reviews 28:2, pages 75-86.
Crossref
Crossref
Martin Martinot, Laetitia Oswald, Elisabeth Parisi, Elodie Etienne, Nicolas Argy, Isabelle Grawey, Dominique De Briel, Mahsa Mohseni Zadeh, Laure Federici, Gilles Blaison, Christelle Koebel, Benoit Jaulhac, Yves Hansmann & Daniel Christmann. (2014) Immunoglobulin deficiency in patients with Streptococcus pneumoniae or Haemophilus influenzae invasive infections. International Journal of Infectious Diseases 19, pages 79-84.
Crossref
Crossref
. 2014. Mollison's Blood Transfusion in Clinical Medicine. Mollison's Blood Transfusion in Clinical Medicine
846
872
.
Arnold I. Levinson. 2014. Stiehm's Immune Deficiencies. Stiehm's Immune Deficiencies
875
887
.
Francis Buadi & Asher Chanan Khan. 2014. Multiple Myeloma. Multiple Myeloma
159
177
.
Christopher P. Conlon. 2013. Myeloma. Myeloma
276
287
.
Guy Pratt & Paul Moss. 2013. Myeloma. Myeloma
84
95
.
Kirsty Cuthill & Stephen Devereux. (2013) How I treat patients with relapsed chronic lymphocytic leukaemia. British Journal of Haematology 163:4, pages 423-435.
Crossref
Crossref
José A. García Marco, Pilar Giraldo Castellano, Javier López Jiménez, Eduardo Ríos Herranz, José Luis Sastre Moral, M. José Terol Casterá & Francesc Bosch Albareda. (2013) Guía de consenso nacionales para el estudio y tratamiento de los pacientes con leucemia linfocítica crónica. Medicina Clínica 141:4, pages 175.e1-175.e8.
Crossref
Crossref
Valérie Gouilleux-Gruart, Nicolas Schleinitz & Alain Fischer. (2013) Primary immune deficiencies. Current Opinion in Allergy & Clinical Immunology 13:Supplement 2, pages S67-S78.
Crossref
Crossref
Konrad Namberger, Lukas Weiss, Barbara Krause, Thomas Melchardt & Richard Greil. (2013) A case of long‐term remission with ofatumumab maintenance therapy in multiply relapsed and rituximab‐refractory chronic lymphocytic leukaemia with deletion 17p. European Journal of Haematology 90:4, pages 349-350.
Crossref
Crossref
Siraj A. Misbah. 2013. Practical Transfusion Medicine. Practical Transfusion Medicine
335
346
.
Miroslav Průcha, R. Zazula, I. Herold, M. Dostál, T. Hyánek & G. Bellingan. (2013) Presence of Hypogammaglobulinemia – A Risk Factor of Mortality in Patients with Severe Sepsis, Septic Shock, and SIRS. Prague Medical Report 114:4, pages 246-257.
Crossref
Crossref
David Oscier, Claire Dearden, Efrem Eren, Christopher Fegan, George Follows, Peter Hillmen, Tim Illidge, Estella Matutes, Don W. Milligan, Andrew Pettitt, Anna Schuh & Jennifer Wimperis. (2012) Guidelines on the diagnosis, investigation and management of chronic lymphocytic leukaemia. British Journal of Haematology 159:5, pages 541-564.
Crossref
Crossref
Trevor Cohen, Dominic Widdows, Roger W. Schvaneveldt, Peter Davies & Thomas C. Rindflesch. (2012) Discovering discovery patterns with predication-based Semantic Indexing. Journal of Biomedical Informatics 45:6, pages 1049-1065.
Crossref
Crossref
Jasper F. W. Chan, Gloria Y. Y. Hwang, Sophia Lamb, Gavin S. W. Chan, Jason C. C. So, Sally S. M. Leung, Kelvin K. W. To, Iris W. S. Li, Vincent C. C. Cheng & Kwok-Yung Yuen. (2011) Pneumococcal native aortic valve endocarditis with mycotic abdominal aortic aneurysm, paraspinal and iliopsoas abscesses and pneumonia revealing a multiple myeloma. Journal of Medical Microbiology 60:6, pages 851-855.
Crossref
Crossref
Frank Rothmann & Georg Maschmeyer. (2011) Die Bestimmung der freien Leichtketten (FreeliteTM) und der Immunglobulin-Kappa/Lambda-Subtypen (HevyliteTM) in der Diagnostik von Plasmazell-Erkrankungen/Serum free light chain and heavy/light chain analysis in patients with monoclonal gammopathy. LaboratoriumsMedizin 35:5, pages 271-278.
Crossref
Crossref
Francesca Gay & Antonio Palumbo. (2010) Management of disease- and treatment-related complications in patients with multiple myeloma. Medical Oncology 27:S1, pages 43-52.
Crossref
Crossref